Skip to content

Price / sales at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
2.1×+0.2×
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
2.9×+0.2×
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
2.5×+0.2×
iRadimed logo
iRadimedIRMD
14.3×+5.4×
Ginkgo Bioworks logo
Ginkgo BioworksDNA
2.7×+1.2×
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
5.6×0.0×

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.5%
Enterprise value$95.86M-31.3%

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Calculated from Rapid Micro Biosystems’s reported figures.

Based on the most recent quarter.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's price / sales?
Rapid Micro Biosystems (RPID) reported price / sales of 3× in Q1 2026.
How has Rapid Micro Biosystems's price / sales changed year-over-year?
Rapid Micro Biosystems's price / sales decreased by 22.0% year-over-year, from 3.9× to 3×.
What is the long-term trend for Rapid Micro Biosystems's price / sales?
Over 4 years (2021 to 2025), Rapid Micro Biosystems's price / sales has grown at a -33.0% compound annual growth rate (CAGR), from 18.9× to 3.8×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.